Large-scale testing (Phase 3)Looking for participantsNCT07717411
What this trial is testing
Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 1,600